Patents by Inventor Gregory D. Ferguson

Gregory D. Ferguson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of micro-RNA as a biomarker of immunomodulatory drug activity
    Patent number: 8771944
    Abstract: Methods of determining the activity of an immunomodulatory compound by measuring the presence of an miRNA in a sample are disclosed. Additionally disclosed are methods of assessing the patient compliance in patients treated with an immunomodulatory compound.
    Type: Grant
    Filed: May 10, 2011
    Date of Patent: July 8, 2014
    Assignee: Celgene Corporation
    Inventors: Gregory D. Ferguson, Helen Brady, Kyle Chan, Normand R. Richard
  • USE OF MIRCO-RNA AS A BIOMARKER OF IMMUNOMODULATORY DRUG ACTIVITY
    Publication number: 20120035068
    Abstract: Methods of determining the activity of an immunomodulatory compound by measuring the presence of an miRNA in a sample are disclosed. Additionally disclosed are methods of assessing the patient compliance in patients treated with an immunomodulatory compound.
    Type: Application
    Filed: May 10, 2011
    Publication date: February 9, 2012
    Inventors: Gregory D. Ferguson, Helen Brady, Kyle Chan, Normand R. Richard
  • Use of micro-RNA as a biomarker of immunomodulatory drug activity
    Patent number: 7964354
    Abstract: Methods of determining the activity of an immunomodulatory compound by measuring the presence of an miRNA in a sample are disclosed. Additionally disclosed are methods of assessing the patient compliance in patients treated with an immunomodulatory compound.
    Type: Grant
    Filed: December 19, 2008
    Date of Patent: June 21, 2011
    Assignee: Celgene Corporation
    Inventors: Gregory D. Ferguson, Helen Brady, Kyle Chan, Normand R. Richard
  • USE OF MICRO-RNA AS A BIOMARKER OF IMMUNOMODULATORY DRUG ACTIVITY
    Publication number: 20090176237
    Abstract: Methods of determining the activity of an immunomodulatory compound by measuring the presence of an miRNA in a sample are disclosed. Additionally disclosed are methods of assessing the patient compliance in patients treated with an immunomodulatory compound.
    Type: Application
    Filed: December 19, 2008
    Publication date: July 9, 2009
    Inventors: Gregory D. Ferguson, Helen Brady, Kyle Chan, Normand R. Richard